Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Progyny Q1 2024 Adj EPS $0.39 Beats $0.13 Estimate, Sales $278.078M Miss $289.457M Estimate

Author: Benzinga Newsdesk | May 09, 2024 04:03pm
Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.13 by 200 percent. The company reported quarterly sales of $278.078 million which missed the analyst consensus estimate of $289.457 million by 3.93 percent. This is a 7.62 percent increase over sales of $258.394 million the same period last year.

Posted In: PGNY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist